
Johnson & Johnson gets CDSCO Panel for additional indication of Amivantamab Liquid Concentrate for Infusion
New Delhi: In a significant development, the drug major Johnson and Johnson has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) for an additional indication of the drug …